ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 152 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 1.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,000 | 0.0% | 12 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | -66.7% | 12 | -69.2% | 0.00% | – |
| Q2 2019 | $3,000 | 0.0% | 39 | +44.4% | 0.00% | – |
| Q1 2019 | $3,000 | -40.0% | 27 | -63.5% | 0.00% | – |
| Q4 2018 | $5,000 | -72.2% | 74 | -91.3% | 0.00% | – |
| Q2 2016 | $18,000 | -30.8% | 849 | -4.8% | 0.00% | – |
| Q1 2016 | $26,000 | +8.3% | 892 | +22.2% | 0.00% | – |
| Q4 2015 | $24,000 | -27.3% | 730 | -21.5% | 0.00% | -100.0% |
| Q3 2015 | $33,000 | -19.5% | 930 | +1.9% | 0.00% | 0.0% |
| Q2 2015 | $41,000 | +46.4% | 913 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $28,000 | -94.5% | 913 | -91.0% | 0.00% | -90.9% |
| Q4 2014 | $513,000 | +5030.0% | 10,098 | +3710.6% | 0.01% | – |
| Q3 2014 | $10,000 | – | 265 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 511,186 | $43,686,000 | 11.23% |
| GREAT POINT PARTNERS LLC | 210,400 | $17,981,000 | 2.80% |
| ARMISTICE CAPITAL, LLC | 456,000 | $38,970,000 | 2.34% |
| Matarin Capital Management, LLC | 210,208 | $17,964,376,000 | 1.16% |
| Sapphire Star Partners LP | 8,168 | $698,000 | 0.70% |
| Granahan Investment Management | 103,320 | $8,830,000 | 0.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 867,500 | $74,137,000 | 0.44% |
| 361 CAPITAL LLC | 19,040 | $1,627,000 | 0.35% |
| ALGERT GLOBAL LLC | 17,922 | $1,532,000 | 0.33% |
| AlphaMark Advisors, LLC | 9,310 | $796,000 | 0.32% |